(Q37600582)

English

The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study

scientific article published on 12 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Childhood Cancer Survivor Study

1 reference

based on heuristic

inferred from title

childhood cancer

1 reference

based on heuristic

inferred from title

Joseph P. Neglia

object named as

Joseph P Neglia

7

0 references

Wendy Leisenring

object named as

Wendy M Leisenring

6

0 references

Marilyn Stovall

12

object named as

Marilyn Stovall

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

14

object named as

Leslie L Robison

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Melissa M. Hudson

10

object named as

Melissa M Hudson

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

9

object named as

Sue C Kaste

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1

object named as

Daniel M Green

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

11

object named as

Lisa R Diller

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

2

object named as

Vikki G Nolan

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Deokumar Srivastava

5

object named as

DeoKumar Srivastava

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sarah S. Donaldson

13

object named as

Sarah S Donaldson

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Pamela J Goodman

3

object named as

Pamela J Goodman

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

4

object named as

John A Whitton

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Charles A Sklar

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

publication date

12 August 2013

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Pediatric Blood Cancer

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

61

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

53-67

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Cyclophosphamide vs melphalan in treatment of plasma cell myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Defining menopausal status: the impact of longitudinal data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Combination chemotherapy of advanced lung cancer.A randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

23 August 2017

Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Multicentre AIDS Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

6 September 2017

Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

14 September 2017

Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

28 September 2017

A comparative study of a bcnu containing 4-drug program versus mopp versus 3-drug combinations in advanced Hodgkin's disease.A cooperative study by the cancer and leukemia group B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

28 September 2017

An investigation of the chest radiographs in a controlled trial of busulphan, cyclophosphamide, and a placebo after resection for carcinoma of the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

28 September 2017

Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

25 June 2018

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

25 June 2018

Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

25 June 2018

Combined cyclophosphamide, vincristine, procarbazine, and prednisone (copp) therapy of malignant lymphoma.Evaluation of 190 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

25 June 2018

Combination chemotherapy in generalized Hodgkin's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

25 June 2018

Acute ovarian failure in the childhood cancer survivor study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

1 September 2018

Genetic effects of radiotherapy for childhood cancer: gonadal dose reconstruction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

1 September 2018

A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

1 September 2018

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

1 September 2018

131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

1 September 2018

Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933293

1 September 2018

Comparison of busulfan and cyclophosphamide in the treatment of chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24679

21 January 2018

MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone sarcomas linked to radiotherapy and chemotherapy in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

alpha-Interferon for remission maintenance: preliminary report on the Southwest Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940101

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PBC.24679

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37600582&oldid=1967122162"